ClassID:

97028

C07K14/705 - page 8 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants

Recent Application in this class:
#2101
20150253303
2015-09-10

LRRC8 proteins and protein complexes and methods for identification of channel modulators

#2102
20150252107
2015-09-10

Antibody modulators of APLNR

#2103
20150252080
2015-09-10

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

#2104
20150252074
2015-09-10

Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes

#2105
20150252035
2015-09-10

Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch

#2106
20150247847
2015-09-03

Diagnostic method for detecting an autoimmune disease

#2107
20150247135
2015-09-03

Broad spectrum ErBB ligand binding molecules and methods for preparing and using them

#2108
20150240303
2015-08-27

Calcium-activated chloride channel involved in human sweat formation

#2109
20150239945
2015-08-27

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#2110
20150238465
2015-08-27

Protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair

#2111
20150232528
2015-08-20

HIGH-EFFICIENCY, SODIUM -SPECIFIC, BLUE-SHIFTED CHANNELRHODOPSINS

#2112
20150231216
2015-08-20

Compound comprising an autoantigenic peptide and a carrier with a MHC binding motif

#2113
20150225470
2015-08-13

Chimeric NK receptor and methods for treating cancer

#2114
20150219628
2015-08-06

Methods for detecting and monitoring endocrine disrupting chemicals (EDCs)

#2115
20150218547
2015-08-06

Cell line, system and method for optical control of secondary messengers

#2116
20150218246
2015-08-06

Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling

#2117
20150216990
2015-08-06

Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto

#2118
20150210751
2015-07-30

Method and composition for crystallizing G protein-coupled receptors

#2119
20150209448
2015-07-30

EXON REPLACEMENT WITH STABILIZED ARTIFICIAL RNAS

#2120
20150203568
2015-07-23

Albumin fusion proteins

#2121
20150203563
2015-07-23

Compositions and methods for treating hypertension

#2122
20150203562
2015-07-23

Compounds and methods for modulating pharmacokinetics

#2123
20150203553
2015-07-23

AAV mediated aquaporin gene transfer to treat Sjogren's syndrome

#2124
20150202256
2015-07-23

Differentiation marker and differentiation control of eye cell

#2125
20150197578
2015-07-16

Anti-Tie2 antibodies and uses thereof

#2126
20150197551
2015-07-16

Methods and compositions for modulating Toso activity

#2127
20150191523
2015-07-09

Toll-like receptors

#2128
20150184201
2015-07-02

Alkane exporter and its use

#2129
20150183880
2015-07-02

Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)

#2130
20150177234
2015-06-25

Nanodisc clathrates and uses thereof

#2131
20150176027
2015-06-25

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#2132
20150175675
2015-06-25

FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

#2133
20150168416
2015-06-18

KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCs)

#2134
20150166631
2015-06-18

ANTI-PRO87299 ANTIBODIES

#2135
20150166630
2015-06-18

BTNL3 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

#2136
20150166629
2015-06-18

SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT

#2137
20150166616
2015-06-18

Modified polynucleotides for the production of cosmetic proteins and peptides

#2138
20150165227
2015-06-18

Light-activated cation channel and uses thereof

#2139
20150158910
2015-06-11

PAR4 agonist peptides

#2140
20150153327
2015-06-04

Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors

#2141
20150152427
2015-06-04

METHOD TO ENGINEER MAMMANLIAN-TYPE CARBOHYDRATE STRUCTURES

#2142
20150152173
2015-06-04

Antibody that binds murine wise protein

#2143
20150151000
2015-06-04

Peptide conjugates for treating pain

#2144
20150148410
2015-05-28

IDENTIFICATION OF SPECIFIC APOLIPOPROTEIN EPITOPES ON CIRCULATING ATHEROGENIC LOW-DENSITY LIPOPROTEIN

#2145
20150148407
2015-05-28

Optogenetic inhibition of overactive neuronal activity

#2146
20150140683
2015-05-21

Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof

#2147
20150140555
2015-05-21

METHOD OF IDENTIFYING FOETAL ERYTHROBLAST

#2148
20150140060
2015-05-21

Compositions and methods for promoting wound healing and tissue regeneration

#2149
20150139995
2015-05-21

Methods and compositions for modulating toso activity

#2150
20150139966
2015-05-21

METHODS OF USING HCN GENES TO TREAT CARDIAC ARRHYTHMIAS

#2151
20150139953
2015-05-21

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#2152
20150139904
2015-05-21

Dendrimer conjugates for coating cells

#2153
20150133637
2015-05-14

P2X7 receptor antagonists and agonists

#2154
20150133363
2015-05-14

GLUT-1 as a receptor for HTLV envelopes and its uses

#2155
20150132803
2015-05-14

Polypeptide for improving protein production in microorganisms of the phylum Labyrinthulomycota

#2156
20150132774
2015-05-14

Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity

#2157
20150126434
2015-05-07

Antimicrobial peptide and use thereof

#2158
20150125514
2015-05-07

BIOMARKER

#2159
20150125477
2015-05-07

Personalized immunotherapy against several neuronal and brain tumors

#2160
20150125442
2015-05-07

Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSK

#2161
20150125384
2015-05-07

Modular nanodevices for smart adaptable vaccines

#2162
20150118158
2015-04-30

Method For Detecting And Purifying Pancreatic Beta Cells

#2163
20150110807
2015-04-23

hDC-sign binding peptides

#2164
20150110798
2015-04-23

Anti-human folate receptor beta antibodies and methods of use

#2165
20150110797
2015-04-23

Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies

#2166
20150110714
2015-04-23

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

#2167
20150105334
2015-04-16

Peptides derived from cytotoxicity receptor natural killer protein 44 NKP44

#2168
20150104462
2015-04-16

Use of semaphorin-4D binding molecules for treatment of atherosclerosis

#2169
20150099297
2015-04-09

CHIMERIC PROTEINS FOR TREATMENT OF DISEASES

#2170
20150098956
2015-04-09

Recombinant polypeptides comprising MHC class II α1 domains

#2171
20150094450
2015-04-02

Repebody for novel interleukin-6 and use thereof

#2172
20150093781
2015-04-02

Microorganism for expressing a human membrane protein

#2173
20150093433
2015-04-02

Targeted and modular exosome loading system

#2174
20150093375
2015-04-02

METHODS FOR INHIBITING OCULAR ANGIOGENESIS

#2175
20150087581
2015-03-26

Immunosuppression modulating compounds

#2176
20150087059
2015-03-26

HIV vpr-specific T-cell receptors

#2177
20150087053
2015-03-26

COMPOSITIONS AND METHODS FOR INCREASING THE EXPRESSION AND SIGNALLING OF PROTEINS ON CELL SURFACES

#2178
20150072927
2015-03-12

Methods and compositions to regulate hepcidin expression

#2179
20150065376
2015-03-05

EXPRESSION CONSTRUCTS ENCODING G PROTEIN COUPLED RECEPTORS AND METHODS OF USE THEREOF

#2180
20150064236
2015-03-05

Modified polynucleotides for the production of proteins

#2181
20150064192
2015-03-05

MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS

#2182
20150064186
2015-03-05

Methods of treating liver conditions using Notch2 antagonists

#2183
20150064150
2015-03-05

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

#2184
20150056252
2015-02-26

Composition and method for diagnosis and immunotherapy of lung cancer

#2185
20150056206
2015-02-26

Multi-specific Fab fusion proteins comprising a CD3-binding Fab fragment with N-terminal fusion to binding domains and methods of use

#2186
20150054713
2015-02-26

Electromagnetic band gap element, electronic circuit, and conductor structure

#2187
20150051152
2015-02-19

Peptide increasing fusiogenic capacity of a gamete

#2188
20150051136
2015-02-19

Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing human sRAGE, and treatment methods using sRAGE

#2189
20150051114
2015-02-19

GENETIC VARIANTS UNDERLYING HUMAN COGNITION AND METHODS OF USE THEREOF AS DIAGNOSTIC AND THERAPEUTIC TARGETS

#2190
20150050296
2015-02-19

METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSES AND AUTOIMMUNITY

#2191
20150050289
2015-02-19

Method of treating motor neuron disease with an antibody that agonizes MuSK

#2192
20150045283
2015-02-12

Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods

#2193
20150044245
2015-02-12

PARTIAL MHC CONSTRUCTS AND METHODS OF USE

#2194
20150038556
2015-02-05

CFTR mRNA compositions and related methods and uses

#2195
20150038426
2015-02-05

Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use

#2196
20150038363
2015-02-05

Method for Stimulating T Cell and Use Thereof

#2197
20150037363
2015-02-05

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

#2198
20150037362
2015-02-05

Modulators of antiviral signaling pathways and therapeutic uses thereof

#2199
20150037296
2015-02-05

Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy

#2200
20150030596
2015-01-29

Bispecific chimeric proteins comprising DARPins

#2201
20150024498
2015-01-22

CLDN5 mini-promoters

#2202
20150024206
2015-01-22

Coated devices and methods for coating

#2203
20150024037
2015-01-22

Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making

#2204
20150023988
2015-01-22

Potent and selective inhibitors of NA1.7

#2205
20150023974
2015-01-22

Toll-like receptor 2 binding epitope and binding member thereto

#2206
20150023968
2015-01-22

Compositions and methods for diagnosing and treating hyperthyroidism in companion animals

#2207
20150018533
2015-01-15

Repebody against immunoglobulin G and uses thereof

#2208
20150017194
2015-01-15

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

#2209
20150017141
2015-01-15

Use of ICOS-based CARs to enhance antitumor activity and CAR persistence

#2210
20150011417
2015-01-08

Membrane span-kinase fusion protein and the uses thereof

#2211
20150005372
2015-01-01

COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS

#2212
20150005177
2015-01-01

Methods of identifying, isolating and using odorant and aroma receptors

#2213
20140377224
2014-12-25

Method of treating or retarding the development of blindness

#2214
20140371161
2014-12-18

Peptides and methods and uses thereof for preventing retinal disorders

#2215
20140370045
2014-12-18

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

#2216
20140363813
2014-12-11

Sperm-specific cation channel, Catsper2, and uses therefor

#2217
20140363446
2014-12-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#2218
20140363423
2014-12-11

Peptide compounds for inhibition of platelet aggregation

#2219
20140359798
2014-12-04

Correction of Crb1 mutations

#2220
20140357521
2014-12-04

Tools and methods for expression of membrane proteins

#2221
20140356896
2014-12-04

Transmembrane protein as biosensors

#2222
20140349399
2014-11-27

Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell

#2223
20140349296
2014-11-27

Methods of enhancing genetic diagnosis

#2224
20140348825
2014-11-27

Compositions and methods to modulate cell activity

#2225
20140342920
2014-11-20

Biomarkers for non-hodgkin lymphomas and uses thereof

#2226
20140341809
2014-11-20

High-affinity DMF5 T cell receptor (TCR) variants

#2227
20140335120
2014-11-13

Dual delivery system for heterologous antigens

#2228
20140335085
2014-11-13

Fusion protein for suppression of autoantibodies

#2229
20140329255
2014-11-06

Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling

#2230
20140323706
2014-10-30

NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF

#2231
20140323693
2014-10-30

Antibodies To Non-Functional P2X7 Receptor

#2232
20140323400
2014-10-30

Use of fibromodulin and lumican for increasing muscle mass

#2233
20140316116
2014-10-23

Methods for screening for binding partners of G-protein coupled receptors

#2234
20140315314
2014-10-23

Engineered and methods of use thereof

#2235
20140315306
2014-10-23

Cell culture substrate comprising a laminin and a cadherin

#2236
20140315299
2014-10-23

Stable proteins

#2237
20140314796
2014-10-23

MARKER FOR NEUROMYELITIS OPTICA

#2238
20140314789
2014-10-23

Method of treating a metabolic disorder induced by obesity in a subject in need thereof by administering MK2/3 inhibitors

#2239
20140304846
2014-10-09

Gene and mutations thereof associated with seizure and movement disorders

#2240
20140303345
2014-10-09

GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same

#2241
20140303231
2014-10-09

Methods and compositions for treating or preventing pruritis

#2242
20140302123
2014-10-09

Products useful for the treatment of malignant neoplasms of the human nervous system

#2243
20140302065
2014-10-09

SOLUBLE UROKINASE RECEPTOR (SUPAR) IN DIABETIC KIDNEY DISEASE

#2244
20140296442
2014-10-02

Antibacterial polymers and method for obtaining the same

#2245
20140295551
2014-10-02

Protein markers associated bone marrow stem cell differentiation into early progentior cells

#2246
20140287510
2014-09-25

Rod cell-specific promoter

#2247
20140287497
2014-09-25

Compositions comprising cells expressing cold- and menthol-sensitive receptor (CMR1) polypeptides

#2248
20140287490
2014-09-25

METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTORS AND ADAPTORS THEREOF

#2249
20140286987
2014-09-25

Methods for controlling T cell proliferation

#2250
20140286973
2014-09-25

Chimeric antigen receptor specific for folate receptor β

#2251
20140286955
2014-09-25

Notch agonists for the treatment of cancer

#2252
20140286925
2014-09-25

Suppression of cancer

#2253
20140275487
2014-09-18

Binding domains directed against GPCR:G protein complexes and uses derived thereof

#2254
20140275227
2014-09-18

Compositions and methods of altering cholesterol levels

#2255
20140274909
2014-09-18

Anti-CD22 chimeric antigen receptors

#2256
20140274904
2014-09-18

Inhibitors of mitochondrial fission and methods of use thereof

#2257
20140273001
2014-09-18

Feline bitter taste receptors and methods

#2258
20140271643
2014-09-18

Human Notch1 decoys

#2259
20140271624
2014-09-18

Anti-notch NRR antibodies and methods using same

#2260
20140256652
2014-09-11

Polypeptides Involved In Immune Response

#2261
20140256613
2014-09-11

PEPTIDE COMPOSITIONS THAT DOWNREGULATE TLR-4 SIGNALING PATHWAY AND METHODS OF PRODUCING AND USING SAME

#2262
20140255467
2014-09-11

MODIFIED POLYNUCLEOTIDES ENCODING CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4

#2263
20140255411
2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#2264
20140255389
2014-09-11

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#2265
20140249208
2014-09-04

Modified polynucleotides for treating protein deficiency

#2266
20140249075
2014-09-04

Methods for reducing CD36 expression

#2267
20140248304
2014-09-04

Non-hemolytic LLO fusion proteins and methods of utilizing same

#2268
20140248260
2014-09-04

Use of Toll-Like Receptor agonist for treating cancer

#2269
20140243277
2014-08-28

Water soluble membrane proteins and methods for the preparation and use thereof

#2270
20140242690
2014-08-28

CYSTIC FIBROSIS TREATMENT

#2271
20140242087
2014-08-28

Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders

#2272
20140235826
2014-08-21

Optically-based stimulation of target cells and modifications thereto

#2273
20140235564
2014-08-21

Methods for treating neural cell swelling

#2274
20140235490
2014-08-21

Methods for detection of botulinum neurotoxin

#2275
20140234326
2014-08-21

Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of TM4SF4 in non-small cell lung cancer

#2276
20140230081
2014-08-14

POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS

#2277
20140227266
2014-08-14

Nogo receptor antagonists and methods of increasing neurite outgrowth

#2278
20140222569
2014-08-07

Communicating a targeted message to a wireless device based on location and two user profiles

#2279
20140221465
2014-08-07

Modified polynucleotides for treating galactosylceramidase protein deficiency

#2280
20140221401
2014-08-07

Methods and compositions for treating pain

#2281
20140220038
2014-08-07

LRP1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (VLDL) to ischaemic cardiac muscle

#2282
20140220011
2014-08-07

Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics

#2283
20140213505
2014-07-31

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

#2284
20140212443
2014-07-31

Immunity to folate receptors

#2285
20140206620
2014-07-24

T cell receptors and related materials and methods of use

#2286
20140206599
2014-07-24

IL4/IL13 binding repeat proteins and uses

#2287
20140200262
2014-07-17

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#2288
20140199371
2014-07-17

Modified polynucleotides encoding basic helix-loop-helix family member E41

#2289
20140199333
2014-07-17

Aquaporin-4 peptide compositions and methods of use thereof

#2290
20140199330
2014-07-17

Protein involved in detection of cancer metastasis and a treatment thereof

#2291
20140199310
2014-07-17

COMPOSITIONS COMPRISING AGENTS THAT INHIBIT NEUROPILIN AND TOLLOID LIKE 2

#2292
20140194595
2014-07-10

Method and composition for crystallizing G protein-coupled receptors

#2293
20140193835
2014-07-10

Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis

#2294
20140193417
2014-07-10

Membrane transporter NaPi2b (SCL34A2) epitope antibodies

#2295
20140193411
2014-07-10

Multimeric constructs

#2296
20140193332
2014-07-10

Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders

#2297
20140187758
2014-07-03

Methods for purifying insect membrane-bound receptor proteins from recombinant production hosts

#2298
20140187494
2014-07-03

Inhibition of inflammation using antagonists of MUC1

#2299
20140186432
2014-07-03

Modified polynucleotides encoding citeD4

#2300
20140186380
2014-07-03

Immunotherapy with binding agents

#2301
20140178986
2014-06-26

SOLUBLE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND USE THEREOF

#2302
20140178392
2014-06-26

Nogo Receptor-Mediated Blockade of Axonal Growth

#2303
20140173764
2014-06-19

ROLE OF PROTEOGLYCANS IN DRUG DEPENDENCE

#2304
20140171376
2014-06-19

Light-sensitive chimeric GPCR protein

#2305
20140165219
2014-06-12

Mutant sodium channel Nav1.7 and methods related thereto

#2306
20140163202
2014-06-12

Phoenixin peptides

#2307
20140162341
2014-06-12

GPCR comprising an IC2 insertion

#2308
20140161873
2014-06-12

Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator

#2309
20140161807
2014-06-12

Methods of promoting CNS neuronal repair by inhibiting LRP-1

#2310
20140155326
2014-06-05

EGFR and C-Met fibronectin type III domain binding molecules

#2311
20140155325
2014-06-05

EGFR and c-Met fibronectin type III domain binding molecules

#2312
20140155314
2014-06-05

Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

#2313
20140154279
2014-06-05

Peptides capable of modulating the function of TIRC7

#2314
20140154238
2014-06-05

Compositions and methods for treating, diagnosing and monitoring disease

#2315
20140147432
2014-05-29

Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders

#2316
20140141461
2014-05-22

Methods for improving and managing nucleoside reverse-transcriptase inhibition based treatment

#2317
20140141067
2014-05-22

Modified polynucleotides encoding septin-4

#2318
20140141026
2014-05-22

GENERATION OF ANTIGEN SPECIFIC T CELLS

#2319
20140135475
2014-05-15

Peptides for inducing antibodies to a non-functional P2Xreceptor

#2320
20140135473
2014-05-15

Bis-sulfhydryl macrocyclization systems

#2321
20140134722
2014-05-15

Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof

#2322
20140134198
2014-05-15

EphA2 T-cell epitope agonists and uses therefore

#2323
20140134194
2014-05-15

HBV EPITOPE REACTIVE EXOGENOUS T CELL RECEPTOR (TCR) AND USES THEREOF

#2324
20140128800
2014-05-08

PHOTOACTIVATABLE RECEPTORS AND THEIR USES

#2325
20140128318
2014-05-08

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

#2326
20140127126
2014-05-08

Compositions and methods for assessing and treating adrenal diseases and disorders

#2327
20140121355
2014-05-01

Drug Screening Target For Alzheimer's Disease and Method of Screening Potential Drugs

#2328
20140121265
2014-05-01

Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids

#2329
20140120553
2014-05-01

Method for identifying compounds that modulate a T2R taste receptor

#2330
20140120106
2014-05-01

Stimulation of Arterial Collateral Growth and Lymphogenesis

#2331
20140113960
2014-04-24

Modified polynucleotides encoding granulysin

#2332
20140107189
2014-04-17

Modified polynucleotides encoding apoptosis inducing factor 1

#2333
20140105966
2014-04-17

Modified polynucleotides encoding hepatitis A virus cellular receptor 2

#2334
20140105965
2014-04-17

Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1

#2335
20140105964
2014-04-17

Modified polynucleotides encoding aquaporin-5

#2336
20140099699
2014-04-10

Nucleic acid molecules encoding non-naturally occurring T cell receptors and cells thereof

#2337
20140096273
2014-04-03

Mouse for predicting a behavior of drugs in humans

#2338
20140093978
2014-04-03

Human Salty Taste Receptor And Methods Of Modulating Salty Taste Perception

#2339
20140093508
2014-04-03

Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists

#2340
20140088292
2014-03-27

Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof

#2341
20140087993
2014-03-27

Pepducin design and use

#2342
20140081004
2014-03-20

Glycosylated specificity exchangers

#2343
20140080156
2014-03-20

Means and methods for diagnosing and treating multiple sclerosis

#2344
20140079698
2014-03-20

ANTI-TUMOR ANTIBODY-TUMOR SUPPRESSOR FUSION PROTEIN COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF CANCER

#2345
20140079643
2014-03-20

Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides

#2346
20140073593
2014-03-13

Bruton's tyrosine kinase as anti-cancer drug target

#2347
20140073572
2014-03-13

Targeting complement factor H for treatment of diseases

#2348
20140073518
2014-03-13

Fusion proteins comprising an engineered knottin peptide and uses thereof

#2349
20140073051
2014-03-13

Method for producing sheet-like pancreatic islet

#2350
20140072968
2014-03-13

Novel Genes Encoding Proteins Having Prognostic, Diagnostic, Preventive, Therapeutic, and Other Uses

#2351
20140066602
2014-03-06

Antibodies that specifically bind SOST and WISE peptides

#2352
20140065673
2014-03-06

Membrane protein expression vector comprising major envelope protein P9 of systovirus PHI12 as a fusion partner and method for producing membrane protein using the same

#2353
20140065643
2014-03-06

G-protein coupled receptor polypeptides involved in sensory transduction

#2354
20140065143
2014-03-06

Inhibition of AXL signaling in anti-metastatic therapy

#2355
20140051645
2014-02-20

Muteins of human lipocalin 2 with affinity for CTLA-4

#2356
20140050726
2014-02-20

Methods and compositions for modulating T cell and/or B cell activation

#2357
20140050708
2014-02-20

Compositions and methods for treating cancer

#2358
20140045180
2014-02-13

Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis

#2359
20140041062
2014-02-06

Genetically engineered mouse model for autism spectrum disorder having deletion of gene and use thereof

#2360
20140039157
2014-02-06

Methods and composition for measuring the amount of vitamin D derivatives

#2361
20140038880
2014-02-06

Compositions and methods for promoting wound healing and tissue regeneration

#2362
20140038286
2014-02-06

Codon optimized sodium-iodide symporter gene and its use

#2363
20140037644
2014-02-06

Method for treating cancer using an antibody that inhibits notch4 signaling

#2364
20140037640
2014-02-06

Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease

#2365
20140031292
2014-01-30

Yeast cell surface display of proteins and uses thereof

#2366
20140031247
2014-01-30

Methods and compositions for gamma-secretase assay

#2367
20140025814
2014-01-23

System and method for monitoring and analyzing internet traffic

#2368
20140024043
2014-01-23

Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1

#2369
20140023671
2014-01-23

TOMM34 peptides and vaccines including the same

#2370
20140023647
2014-01-23

METHOD FOR TREATING SOLID TUMORS

#2371
20140018257
2014-01-16

Peptide library production method, peptide library, and screening method

#2372
20140017259
2014-01-16

Immunotherapy against ErbB-3 receptor

#2373
20140017251
2014-01-16

Botulinum neurotoxin a receptor and the use thereof

#2374
20140011744
2014-01-09

Method for regulating neurite growth

#2375
20140010798
2014-01-09

Treatment with factor ix-albumin fusion protein

#2376
20140004535
2014-01-02

E518A/K mutant smoothened and methods of using the same

#2377
20140004095
2014-01-02

Treatment with factor VII-albumin fusion protein

#2378
20130345138
2013-12-26

Polypeptides derived from calcitonin receptors and methods of use

#2379
20130345092
2013-12-26

T1R taste receptors and genes encoding same

#2380
20130338034
2013-12-19

Metabolic diseases-related odorant receptor genes and use thereof

#2381
20130337472
2013-12-19

Cell division marker

#2382
20130336958
2013-12-19

NOTCH inhibition in the treatment of cardiovascular disease

#2383
20130331441
2013-12-12

Cell line, system and method for optical control of secondary messengers

#2384
20130331333
2013-12-12

PAR1 and PAR2 c-tail peptides and peptide mimetics

#2385
20130324698
2013-12-05

ANTI-SYNDECAN-4 ANTIBODIES

#2386
20130317091
2013-11-28

Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases

#2387
20130316957
2013-11-28

SMOOTHENED POLYPEPTIDES AND METHODS OF USE

#2388
20130316911
2013-11-28

Methods and compositions for screening and treating developmental disorders

#2389
20130315938
2013-11-28

Delivering polypeptides to phagocytes

#2390
20130315915
2013-11-28

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES

#2391
20130315912
2013-11-28

Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs

#2392
20130303456
2013-11-14

METHOD OF TREATING ABNORMAL ANGIOGENESIS VIA THE BAI FAMILY OF PROTEINS AND THEIR PROTEIN FRAGMENTS

#2393
20130302823
2013-11-14

Methods of screening T1R1/T1R3 receptors for compounds that modulate umami taste signaling

#2394
20130302339
2013-11-14

COMPOSITIONS FOR DIAGNOSIS AND THERAPY OF DISEASES ASSOCIATED WITH ABERRANT EXPRESSION OF KREMEN AND OR WNT

#2395
20130302270
2013-11-14

Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucleic acids encoding the same

#2396
20130296406
2013-11-07

Optically-based stimulation of target cells and modifications thereto

#2397
20130295063
2013-11-07

High affinity HIV T cell receptors

#2398
20130289238
2013-10-31

PAR4 agonist peptides

#2399
20130288983
2013-10-31

Variant activin receptor polypeptides and uses thereof

#2400
20130287785
2013-10-31

Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof